indirubin-3'-monoxime has been researched along with Carcinoma, Hepatocellular in 2 studies
indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, T | 2 |
| Ohashi, S | 1 |
| Saito, H | 1 |
| Wada, T | 1 |
| Aoyama, T | 1 |
| Ichimaru, Y | 1 |
| Miyairi, S | 1 |
| Kobayashi, S | 2 |
| Kasai, M | 1 |
2 other studies available for indirubin-3'-monoxime and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Indirubin 3'-oxime inhibits anticancer agent-induced YB-1 nuclear translocation in HepG2 human hepatocellular carcinoma cells.
Topics: Active Transport, Cell Nucleus; Angiogenesis Inhibitors; Antineoplastic Agents; Carcinoma, Hepatocel | 2018 |
Mechanism responsible for inhibitory effect of indirubin 3'-oxime on anticancer agent-induced YB-1 nuclear translocation in HepG2 human hepatocellular carcinoma cells.
Topics: Antineoplastic Agents; beta Karyopherins; Carcinoma, Hepatocellular; Cell Nucleus; Hep G2 Cells; Hum | 2018 |